BUSTI, Fabiana
 Distribuzione geografica
Continente #
NA - Nord America 1.888
EU - Europa 1.418
AS - Asia 604
AF - Africa 5
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 3.926
Nazione #
US - Stati Uniti d'America 1.882
GB - Regno Unito 515
CN - Cina 443
SE - Svezia 216
IE - Irlanda 157
FR - Francia 149
IT - Italia 107
DE - Germania 96
FI - Finlandia 95
SG - Singapore 54
UA - Ucraina 28
JP - Giappone 23
BE - Belgio 20
KR - Corea 20
VN - Vietnam 19
HK - Hong Kong 11
IR - Iran 10
IN - India 6
RU - Federazione Russa 6
AU - Australia 5
CA - Canada 5
CZ - Repubblica Ceca 5
GR - Grecia 5
IQ - Iraq 4
CH - Svizzera 3
ES - Italia 3
EU - Europa 3
PK - Pakistan 3
TR - Turchia 3
AT - Austria 2
EG - Egitto 2
HR - Croazia 2
ID - Indonesia 2
NL - Olanda 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
MD - Moldavia 1
MU - Mauritius 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.926
Città #
Southend 463
Chandler 416
Jacksonville 226
Ann Arbor 164
Dublin 155
Woodbridge 130
Ashburn 108
Beijing 94
New York 89
Wilmington 66
Houston 64
Lawrence 59
Princeton 59
Jinan 42
Boardman 40
Nanjing 40
Helsinki 37
Singapore 36
Verona 29
Shenyang 26
Tokyo 23
Lancaster 20
Redmond 20
Brussels 18
Haikou 18
Sindelfingen 18
Hebei 17
Falls Church 16
Ningbo 16
Seoul 16
Zhengzhou 16
Nanchang 15
Tianjin 14
Seattle 13
Changsha 12
Taizhou 11
Guangzhou 10
Redwood City 10
Taiyuan 10
Jiaxing 9
Fuzhou 8
Milan 8
Norwalk 8
Lanzhou 7
Tehran 7
Fairfield 6
Hangzhou 6
San Francisco 6
Dong Ket 5
Hong Kong 5
Nettuno 5
Brno 4
Cagliari 4
Chions 4
Düsseldorf 4
Los Angeles 4
Seongbuk-gu 4
Toronto 4
Washington 4
Alexandria 3
Athens 3
Bangalore 3
Cerea 3
Kent 3
Kirkuk 3
Mehlingen 3
Rome 3
San Mateo 3
Zurich 3
Bandung 2
Berlin 2
Cairo 2
Canberra 2
Central 2
Chicago 2
Corridonia 2
Dearborn 2
Dongguan 2
Frankfurt am Main 2
Gunzenhausen 2
Kish 2
Kochi 2
Lappeenranta 2
London 2
Madrid 2
Mestre 2
Randolph 2
San Diego 2
San Martino Buon Albergo 2
Taranto 2
Waanrode 2
Wah 2
Alpignano 1
Andover 1
Ardabil 1
Auburn Hills 1
Augusta 1
Austin 1
Bacoli 1
Badia Polesine 1
Totale 2.832
Nome #
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 121
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 117
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 108
A challenging case of abdominal pain associated to Helicobacter pylori infection 101
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 101
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 96
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 94
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 94
Paraoxonase-1 status in patients with hereditary hemochromatosis 94
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 93
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 92
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 92
Identification of new BMP6 pro-peptide mutations in patients with iron overload 92
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 89
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 89
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 87
Altered paraoxonase expression in patients with genetic haemochromatosis. 86
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 85
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 84
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 83
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 82
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 80
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 78
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 76
Reduced serum hepcidin levels in patients with chronic hepatitis C 74
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 73
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 71
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 70
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 64
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 60
Paraoxonase-1 status in patients with hereditary hemochromatosis. 59
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 59
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 57
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 55
Modern iron replacement therapy: clinical and pathophysiological insights 54
Iron deficiency in the elderly population, revisited in the hepcidin era. 53
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 53
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 53
COBALAMIN DEFICIENCY IN THE ELDERLY 52
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 52
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 47
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 47
Iron replacement in inflammatory bowel disease: an evolving scenario 46
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 46
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 45
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 45
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 44
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 44
Hyperferritinemia and diagnosis of type 1 Gaucher disease 44
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 41
Impact of natural Neuromedin-B receptor variants on iron metabolism 39
Treatment options for anemia in the elderly 39
ERFE regulation in sickle cell disease: complex but promising 39
Iron metabolism in infections: Focus on COVID-19 39
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 33
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 32
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 31
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 29
Hemochromatosis classification: update and recommendations by the BIOIRON Society 17
New Insights into the Role of Ferroptosis in Cardiovascular Diseases 12
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 12
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine 10
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 9
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 8
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 8
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 7
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 5
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 4
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 3
Recent Advancement of Hematology: Know, How to Do, Let Know 3
Manipulating hepcidin in polycythemia vera 2
Totale 4.003
Categoria #
all - tutte 13.531
article - articoli 9.748
book - libri 0
conference - conferenze 3.604
curatela - curatele 0
other - altro 179
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020371 40 9 4 28 62 36 36 21 31 49 18 37
2020/2021434 19 76 22 49 78 52 18 17 10 18 50 25
2021/2022530 15 159 3 63 20 23 7 28 20 17 50 125
2022/20231.143 67 132 94 198 100 254 22 87 139 4 24 22
2023/2024665 21 36 49 58 54 149 21 48 7 32 96 94
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 4.003